You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydralazine Hydrochloride W/ Hydrochlorothiazide 100/50, and when can generic versions of Hydralazine Hydrochloride W/ Hydrochlorothiazide 100/50 launch?

Hydralazine Hydrochloride W/ Hydrochlorothiazide 100/50 is a drug marketed by Ivax Pharms and is included in one NDA.

The generic ingredient in HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 is hydralazine hydrochloride; hydrochlorothiazide. There are twenty-one drug master file entries for this compound. Additional details are available on the hydralazine hydrochloride; hydrochlorothiazide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50?
  • What are the global sales for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50?
  • What is Average Wholesale Price for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50?
Summary for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50
Drug patent expirations by year for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50
Recent Clinical Trials for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Center for Research Resources (NCRR)Phase 4
Vanderbilt University Medical CenterPhase 4
Vanderbilt UniversityPhase 1

See all HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 clinical trials

US Patents and Regulatory Information for HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Pharms HYDRALAZINE HYDROCHLORIDE W/ HYDROCHLOROTHIAZIDE 100/50 hydralazine hydrochloride; hydrochlorothiazide CAPSULE;ORAL 088358-001 Apr 10, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.